Schouw & Co. shares surge 8% as stronger Q2 earnings trigger major 2026 guidance hike

Schouw & Co. delivered a stronger-than-expected second quarter as improving profitability across its diversified industrial portfolio pushed EBITDA up 17% year over year and prompted management to raise its full-year 2026 guidance. Quarterly revenue increased approximately 5% to DKK 9.2 billion, while EBITDA reached roughly DKK 878 million and EBIT climbed 25% to DKK 533 million. Profit before tax increased 42%, demonstrating that the earnings improvement extended well beyond the top line as operational efficiencies and stronger activity benefited several portfolio companies. Schouw & Co. now expects 2026 revenue of DKK 34.8 billion to DKK 37.2 billion and EBITDA of DKK 3.15 billion to DKK 3.35 billion, compared with previous forecasts of DKK 33 billion to DKK 35.5 billion and DKK 2.9 billion to DKK 3.2 billion respectively.

Investors responded decisively to the upgraded outlook. Schouw & Co. shares were trading around DKK 686 on August 14, up approximately 7.7% from the previous close, after reaching about DKK 689 during the session. The move suggests investors viewed the guidance increase as more than a temporary earnings beat, particularly because all six portfolio companies either maintained or improved their individual expectations for revenue or EBITDA.

The breadth of the improvement is particularly important for a conglomerate whose businesses span aquaculture feed, electronics manufacturing, hydraulic systems, automotive components and nonwoven materials. BioMar remains the largest earnings contributor, but GPV, HydraSpecma, Fibertex Nonwovens and Fibertex Personal Care all delivered meaningful improvements during the quarter, reducing the risk that the upgraded outlook depends entirely on one operating company.

BioMar’s record feed volumes remain central to Schouw & Co.’s stronger earnings outlook

BioMar continued to anchor the group, generating approximately DKK 4.2 billion in second-quarter revenue and DKK 357 million of EBITDA. Revenue increased about 5%, while EBITDA rose approximately 2%, with the underlying feed business producing stronger earnings as volumes reached a quarterly record.

Volume growth is particularly significant because aquaculture feed economics can be affected by raw-material prices, customer mix and changes in salmon and shrimp farming activity. Higher feed volumes give BioMar additional operating leverage while strengthening its position with large aquaculture producers, although commodity movements can cause revenue growth and physical volume growth to diverge from one another.

Schouw & Co. raised BioMar’s full-year expectations alongside the group outlook. The portfolio company now expects 2026 EBITDA between approximately DKK 1.62 billion and DKK 1.72 billion, indicating that management sees the stronger operating performance continuing beyond the first half.

BioMar’s importance extends beyond its immediate earnings contribution because Schouw & Co. has been evaluating the next strategic phase for the aquaculture business. Earlier in 2026, management said it had begun assessing a potential initial public offering of BioMar after years of preparing the business for greater strategic flexibility, meaning continued earnings growth could influence both valuation and timing if that process advances.

A potential listing would represent a major capital-allocation decision for Schouw & Co. because BioMar is one of its most valuable portfolio assets. A public-market valuation could crystallize value that is difficult for investors to isolate inside the conglomerate structure, while Schouw & Co. could potentially retain a substantial ownership interest and continue benefiting from BioMar’s longer-term growth.

The stronger second quarter therefore improves both the operating and strategic backdrop. Record feed volumes support near-term earnings, while a higher earnings base could strengthen BioMar’s positioning if Schouw & Co. eventually decides that public ownership offers greater value than keeping the business entirely within the existing portfolio.

GPV and HydraSpecma show why Schouw & Co.’s Q2 improvement extends beyond aquaculture

GPV delivered one of the clearest examples of earnings growing much faster than revenue. Second-quarter revenue was broadly stable at approximately DKK 2.2 billion, while EBITDA increased about 20% to DKK 187 million and EBITDA margin improved to approximately 8.3%.

Management indicated that much of GPV’s improvement came from efficiency initiatives rather than stronger pricing or dramatic volume expansion. That distinction is encouraging because productivity-driven earnings can prove more durable than profitability dependent exclusively on favorable market pricing, particularly for an electronics manufacturing business exposed to shifting customer demand and global supply chains.

GPV nevertheless continues to operate in a mixed demand environment, making the margin improvement especially relevant. Schouw & Co. narrowed the company’s full-year revenue expectation to approximately DKK 8.6 billion to DKK 9 billion and EBITDA to DKK 710 million to DKK 750 million, suggesting greater visibility but not an assumption of explosive end-market growth.

HydraSpecma produced a more conventional combination of volume and earnings growth. Revenue increased approximately 12% to DKK 925 million, while EBITDA jumped about 30% to DKK 125 million, producing one of the strongest percentage earnings increases across the portfolio.

The company supplies hydraulic and electrification solutions to industrial customers, giving Schouw & Co. exposure to machinery, mobile equipment and increasingly electrified industrial systems. Management raised HydraSpecma’s 2026 revenue forecast to DKK 3.4 billion to DKK 3.6 billion and EBITDA guidance to DKK 430 million to DKK 460 million following the stronger performance.

Together, GPV and HydraSpecma demonstrate why the Schouw & Co. guidance increase carries more weight than a single-company earnings surprise. One business is generating improved returns largely through efficiency, while another is combining higher activity with operating leverage, giving the portfolio multiple pathways to earnings growth.

Fibertex businesses accelerate as efficiency gains broaden the portfolio’s earnings recovery

Fibertex Nonwovens was another standout contributor during the second quarter. Revenue increased approximately 20% to DKK 700 million, while EBITDA surged 48% to DKK 84 million as the business benefited from higher activity and improved operating efficiency.

The company manufactures nonwoven materials used across applications including automotive components, construction, filtration and industrial products. Schouw & Co. had already reported improving efficiency at Fibertex Nonwovens earlier in 2026, particularly in the United States, while a new spunlacing production line in the Czech Republic is expected to support further growth as commercial production ramps during the second half.

Full-year expectations were raised accordingly. Fibertex Nonwovens now expects revenue between DKK 2.5 billion and DKK 2.7 billion and EBITDA between DKK 230 million and DKK 260 million, increasing the contribution expected from what had previously been one of Schouw & Co.’s smaller earnings businesses.

Fibertex Personal Care also improved profitability, with EBITDA rising roughly 23% to DKK 59 million during the quarter. Management increased its 2026 guidance to revenue of DKK 1.7 billion to DKK 1.9 billion and EBITDA of DKK 160 million to DKK 180 million, providing another incremental source of improvement at group level.

Borg Automotive remained less spectacular but still contributed to the broader improvement. Revenue declined approximately 5% to DKK 461 million, while EBITDA increased to around DKK 38 million, showing that profitability can improve even when end-market sales remain constrained.

Schouw & Co. maintained Borg Automotive’s revenue expectations while raising the company’s EBITDA range to DKK 90 million to DKK 110 million. The contrast between weaker revenue and higher expected earnings reinforces a recurring theme across the portfolio, with productivity, cost control and operational optimization playing a larger role in the 2026 earnings upgrade than pure top-line acceleration alone.

Higher 2026 guidance raises expectations as Spectre acquisition adds another growth layer

Schouw & Co. raised consolidated 2026 revenue guidance to DKK 34.8 billion to DKK 37.2 billion from DKK 33 billion to DKK 35.5 billion. The midpoint increased by approximately DKK 1.75 billion, reflecting stronger expectations across the portfolio as well as the anticipated contribution from acquisition activity.

EBITDA guidance increased to DKK 3.15 billion to DKK 3.35 billion from DKK 2.9 billion to DKK 3.2 billion. At the midpoint, the new forecast implies approximately DKK 200 million more EBITDA than previously anticipated and would place full-year earnings comfortably above the DKK 2.88 billion generated in 2025.

The pending Spectre acquisition will add another business to the portfolio and is expected to close during the third or early fourth quarter of 2026. Schouw & Co. expects Spectre to contribute approximately DKK 300 million to DKK 400 million of revenue during 2026, although its initial EBITDA contribution is expected to be limited.

That transaction means investors should separate organic operating improvement from acquisition-driven revenue when assessing the new guidance. The stronger EBITDA outlook appears to be supported primarily by better performance across existing businesses, while Spectre adds more significantly to revenue than to near-term earnings.

The distinction is favorable because acquisition revenue can inflate the size of a company without immediately improving shareholder returns. Schouw & Co.’s second-quarter results instead show meaningful margin and earnings improvements already occurring across GPV, HydraSpecma and the Fibertex companies before Spectre becomes a significant contributor.

Capital allocation will remain important as the group simultaneously evaluates BioMar’s future, completes acquisitions and maintains investment across its existing businesses. Schouw & Co.’s long-standing model is based on active ownership of industrial companies rather than rapid portfolio turnover, so the value of the latest investments will depend on whether management can reproduce the operational improvements visible across its current holdings.

Schouw & Co. stock surge suggests investors see the guidance increase as a broader earnings reset

Schouw & Co. shares climbed to around DKK 686 on August 14, up approximately 7.7% from the previous close of DKK 637. The stock traded as high as roughly DKK 689, making the earnings release one of the strongest immediate positive catalysts for the shares in recent months.

The rally is notable because Schouw & Co. had underperformed broader markets before the results. The stronger Q2 numbers and guidance increase provide investors with a reason to revisit the valuation, particularly if higher portfolio-company earnings make the underlying businesses more valuable than the conglomerate’s market capitalization previously implied.

Investor sentiment also benefits from the breadth of the earnings improvement. BioMar delivered record volumes, GPV improved efficiency, HydraSpecma produced double-digit growth and both Fibertex companies lifted earnings, reducing the likelihood that the full-year guidance increase depends on one unusually favorable market condition.

The risks remain diversified as well. Aquaculture demand and raw-material prices affect BioMar, electronics cycles influence GPV, industrial capital spending matters for HydraSpecma and automotive and construction trends can influence the Fibertex businesses, meaning weakness in several end markets could still challenge the upgraded targets.

The second quarter nevertheless gives Schouw & Co. a stronger foundation entering the second half. If operating efficiencies persist and portfolio companies deliver within their newly raised expectations, the company could finish 2026 with record EBITDA while simultaneously adding Spectre and advancing strategic options for BioMar.

That possibility explains why the August 14 stock reaction was so strong. Investors are not simply rewarding one quarter of higher earnings; they appear to be pricing in the possibility that Schouw & Co.’s diversified industrial portfolio has entered a stronger profitability phase than was reflected in the company’s previous 2026 guidance.

Key takeaways from Schouw & Co.’s Q2 earnings and higher 2026 guidance

• Schouw & Co. Q2 revenue increased about 5% to DKK 9.2 billion, while EBITDA climbed 17% to approximately DKK 878 million.
• EBIT rose 25% to DKK 533 million and profit before tax increased 42%, showing earnings growth substantially outpaced revenue.
• BioMar delivered record feed volumes and approximately DKK 357 million of quarterly EBITDA.
• GPV EBITDA increased 20% to DKK 187 million despite broadly stable revenue, reflecting improved operating efficiency.
• HydraSpecma revenue rose 12% and EBITDA jumped 30% to approximately DKK 125 million.
• Fibertex Nonwovens EBITDA surged 48% to DKK 84 million as higher activity and efficiency supported margins.
• Full-year revenue guidance increased to DKK 34.8 billion-DKK 37.2 billion from DKK 33 billion-DKK 35.5 billion.
• EBITDA guidance rose to DKK 3.15 billion-DKK 3.35 billion from the previous DKK 2.9 billion-DKK 3.2 billion range.
• The pending Spectre acquisition is expected to add DKK 300 million-DKK 400 million of 2026 revenue after closing.
• Schouw & Co. shares surged approximately 7.7% to DKK 686 on August 14 as investors rewarded the broad-based guidance upgrade.